Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 556

1.

Coronary artery calcification as a novel predictive marker of unstable coronary lesion in survivors of out-of-hospital cardiac arrest without ST-segment elevation.

Matsumura K, Otagaki M, Fujii K, Shibutani H, Morishita S, Hashimoto K, Tsujimoto S, Yamamoto Y, Sugiura T, Shiojima I.

Resuscitation. 2019 Dec 31;147:67-72. doi: 10.1016/j.resuscitation.2019.12.019. [Epub ahead of print]

PMID:
31901459
2.

Cerebral Oxygenation Dynamics of the Prefrontal Cortex and Motor-Related Area During Cardiopulmonary Exercise Test: A Near-Infrared Spectroscopy Study.

Kojima S, Morishita S, Qin W, Tsubaki A.

Adv Exp Med Biol. 2020;1232:231-237. doi: 10.1007/978-3-030-34461-0_29.

PMID:
31893415
3.

Relationship Between Exercise Capacity and Muscle O2Hb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation.

Morishita S, Wakasugi T, Kaida K, Itani Y, Ikegame K, Ogawa H, Fujimori Y, Domen K.

Adv Exp Med Biol. 2020;1232:215-221. doi: 10.1007/978-3-030-34461-0_27.

PMID:
31893413
4.

Comparison of the Effects of Continuous and Intermittent Exercise on Cerebral Oxygenation and Cognitive Function.

Ichinose Y, Morishita S, Suzuki R, Endo G, Tsubaki A.

Adv Exp Med Biol. 2020;1232:209-214. doi: 10.1007/978-3-030-34461-0_26.

PMID:
31893412
5.

Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease.

Wakasugi T, Morishita S, Kaida K, Itani Y, Ikegame K, Kodama N, Ogawa H, Fujimori Y, Domen K.

Adv Exp Med Biol. 2020;1232:201-207. doi: 10.1007/978-3-030-34461-0_25.

PMID:
31893411
6.

Effect of Exercise Duration on Post-Exercise Persistence of Oxyhemoglobin Changes in the Premotor Cortex: A Near-Infrared Spectroscopy Study in Moderate-Intensity Cycling Exercise.

Tsubaki A, Morishita S, Tokunaga Y, Sato D, Qin W, Kojima S, Onishi H.

Adv Exp Med Biol. 2020;1232:193-199. doi: 10.1007/978-3-030-34461-0_24.

PMID:
31893410
7.

A Novel de novoKIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, And Spastic Paraplegia.

Kurihara M, Ishiura H, Bannai T, Mitsui J, Yoshimura J, Morishita S, Hayashi T, Shimizu J, Toda T, Tsuji S.

Intern Med. 2019 Dec 6. doi: 10.2169/internalmedicine.3661-19. [Epub ahead of print]

8.

Acute moderate-intensity exercise improves 24-h sleep deprivation-induced cognitive decline and cerebral oxygenation: A near-infrared spectroscopy study.

Kojima S, Abe T, Morishita S, Inagaki Y, Qin W, Hotta K, Tsubaki A.

Respir Physiol Neurobiol. 2019 Dec 3;274:103354. doi: 10.1016/j.resp.2019.103354. [Epub ahead of print]

PMID:
31809903
9.

Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With Sepsis.

Mitobe Y, Morishita S, Ohashi K, Sakai S, Uchiyama M, Abeywickrama H, Yamada E, Kikuchi Y, Nitta M, Honda T, Endoh H, Kimura S, Sakano S, Koyama Y.

J Clin Med Res. 2019 Dec;11(12):834-841. doi: 10.14740/jocmr4027. Epub 2019 Nov 24.

10.

The Mini Nutritional Assessment-Short Form as a predictor of nursing home mortality in Japan: A 30-month longitudinal study.

Motokawa K, Yasuda J, Mikami Y, Edahiro A, Morishita S, Shirobe M, Ohara Y, Nohara K, Hirano H, Watanabe Y.

Arch Gerontol Geriatr. 2020 Jan - Feb;86:103954. doi: 10.1016/j.archger.2019.103954. Epub 2019 Sep 12.

PMID:
31710866
11.

Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells.

Ozawa S, Tsujimoto M, Uchiyama H, Ito N, Morishita S, Yamamoto M, Irie R, Sakashita T, Tachiki H, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K.

Sci Rep. 2019 Oct 29;9(1):15464. doi: 10.1038/s41598-019-51640-9.

12.

Efficacies of ultrasound and a handheld dynamometer to predict one-repetition maximum.

Nakamura M, Sutoh S, Kiyono R, Sato S, Yahata K, Hiraizumi K, Morishita S.

J Phys Ther Sci. 2019 Oct;31(10):790-794. doi: 10.1589/jpts.31.790. Epub 2019 Oct 19.

13.

Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology.

Ojima-Kato T, Morishita S, Uchida Y, Nagai S, Kojima T, Nakano H.

Antibodies (Basel). 2018 Nov 7;7(4). pii: E38. doi: 10.3390/antib7040038.

14.

Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.

Ishii K, Yamashita H, Yamaguchi M, Komatsu Y, Ryu E, Morishita S, Matsuo K, Kamada M, Ikeda T, Ashizawa K, Hara T.

Intern Med. 2020 Jan 15;59(2):293-296. doi: 10.2169/internalmedicine.3098-19. Epub 2019 Sep 18.

15.

Long-read metagenomic exploration of extrachromosomal mobile genetic elements in the human gut.

Suzuki Y, Nishijima S, Furuta Y, Yoshimura J, Suda W, Oshima K, Hattori M, Morishita S.

Microbiome. 2019 Aug 27;7(1):119. doi: 10.1186/s40168-019-0737-z.

16.

Shootins mediate collective cell migration and organogenesis of the zebrafish posterior lateral line system.

Urasaki A, Morishita S, Naka K, Uozumi M, Abe K, Huang L, Watase E, Nakagawa O, Kawakami K, Matsui T, Bessho Y, Inagaki N.

Sci Rep. 2019 Aug 21;9(1):12156. doi: 10.1038/s41598-019-48585-4.

17.

JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.

Inano T, Araki M, Morishita S, Imai M, Yasuda H, Nitta H, Ito M, Edahiro Y, Ochiai T, Misawa K, Fukuda Y, Ohsaka A, Komatsu N.

Br J Haematol. 2019 Oct;187(1):e27-e31. doi: 10.1111/bjh.16146. Epub 2019 Aug 16. No abstract available.

PMID:
31418453
18.
19.

Position and momentum mapping of vibrations in graphene nanostructures.

Senga R, Suenaga K, Barone P, Morishita S, Mauri F, Pichler T.

Nature. 2019 Sep;573(7773):247-250. doi: 10.1038/s41586-019-1477-8. Epub 2019 Aug 12.

PMID:
31406319
20.

Novel effects of rooibos extract on tear and saliva secretion mediated by the muscarinic acetylcholine receptor 3 in mice.

Arakaki R, Ushio A, Kisoda S, Sato M, Nakamura Y, Yuyama K, Tateyama R, Morishita S, Monoi N, Kudo Y, Ishimaru N.

J Oral Biosci. 2019 Sep;61(3):179-182. doi: 10.1016/j.job.2019.06.001. Epub 2019 Aug 7.

PMID:
31400544
21.

Differential influence of lesion length on fractional flow reserve in intermediate coronary lesions between each coronary artery.

Shibutani H, Fujii K, Matsumura K, Otagaki M, Morishita S, Bando K, Motohiro M, Umemura S, Shiojima I.

Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28430. [Epub ahead of print]

PMID:
31400081
22.

Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease.

Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K, Almansour MA, Kikuchi JK, Taira M, Mitsui J, Takahashi Y, Ichikawa Y, Mano T, Iwata A, Harigaya Y, Matsukawa MK, Matsukawa T, Tanaka M, Shirota Y, Ohtomo R, Kowa H, Date H, Mitsue A, Hatsuta H, Morimoto S, Murayama S, Shiio Y, Saito Y, Mitsutake A, Kawai M, Sasaki T, Sugiyama Y, Hamada M, Ohtomo G, Terao Y, Nakazato Y, Takeda A, Sakiyama Y, Umeda-Kameyama Y, Shinmi J, Ogata K, Kohno Y, Lim SY, Tan AH, Shimizu J, Goto J, Nishino I, Toda T, Morishita S, Tsuji S.

Nat Genet. 2019 Aug;51(8):1222-1232. doi: 10.1038/s41588-019-0458-z. Epub 2019 Jul 22.

PMID:
31332380
23.

Assessment of the Mini-Balance Evaluation Systems Test, Timed Up and Go test, and body sway test between cancer survivors and healthy participants.

Morishita S, Hirabayashi R, Tsubaki A, Aoki O, Fu JB, Onishi H, Tsuji T.

Clin Biomech (Bristol, Avon). 2019 Oct;69:28-33. doi: 10.1016/j.clinbiomech.2019.07.002. Epub 2019 Jul 2.

PMID:
31288138
24.

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Maekawa T, Kato S, Kawamura T, Takada K, Sone T, Ogata H, Saito K, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Horiuchi T, Hikota-Saga R, Endo-Umeda K, Uno S, Osawa Y, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Usuki K, Morishita S, Araki M, Makishima M, Komatsu N, Kimura F.

Blood. 2019 Sep 5;134(10):814-825. doi: 10.1182/blood.2019000051. Epub 2019 Jul 3.

PMID:
31270105
25.

Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42.

Hashiguchi S, Doi H, Kunii M, Nakamura Y, Shimuta M, Suzuki E, Koyano S, Okubo M, Kishida H, Shiina M, Ogata K, Hirashima F, Inoue Y, Kubota S, Hayashi N, Nakamura H, Takahashi K, Katsumoto A, Tada M, Tanaka K, Sasaoka T, Miyatake S, Miyake N, Saitsu H, Sato N, Ozaki K, Ohta K, Yokota T, Mizusawa H, Mitsui J, Ishiura H, Yoshimura J, Morishita S, Tsuji S, Takeuchi H, Ishikawa K, Matsumoto N, Ishikawa T, Tanaka F.

Neurobiol Dis. 2019 Oct;130:104516. doi: 10.1016/j.nbd.2019.104516. Epub 2019 Jun 20.

PMID:
31229688
26.

Retrospective Analysis of Acute Rehabilitation Outcomes of Cancer Inpatients with Leptomeningeal Disease.

Fu JB, Molinares DM, Morishita S, Silver JK, Dibaj SS, Guo Y, Bruera E.

PM R. 2019 Jun 21. doi: 10.1002/pmrj.12207. [Epub ahead of print]

PMID:
31222952
27.

The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation.

Morishita S, Tsubaki A, Hotta K, Fu JB, Fuji S.

J Int Soc Phys Rehabil Med. 2019 Jan-Mar;2(1):54-61. doi: 10.4103/jisprm.jisprm_2_19. Epub 2019 May 22.

PMID:
31131374
28.

Atomic resolution electron microscopy in a magnetic field free environment.

Shibata N, Kohno Y, Nakamura A, Morishita S, Seki T, Kumamoto A, Sawada H, Matsumoto T, Findlay SD, Ikuhara Y.

Nat Commun. 2019 May 24;10(1):2308. doi: 10.1038/s41467-019-10281-2.

29.

Recompleting the Caenorhabditis elegans genome.

Yoshimura J, Ichikawa K, Shoura MJ, Artiles KL, Gabdank I, Wahba L, Smith CL, Edgley ML, Rougvie AE, Fire AZ, Morishita S, Schwarz EM.

Genome Res. 2019 Jun;29(6):1009-1022. doi: 10.1101/gr.244830.118. Epub 2019 May 23.

30.

Scleral patch grafting for scleral wound thinning after pars plana phacoemulsification and aspiration: A case report.

Terubayashi Y, Morishita S, Fukumoto M, Sato T, Kida T, Ikeda T.

Medicine (Baltimore). 2019 May;98(19):e15598. doi: 10.1097/MD.0000000000015598.

31.

Qualitative analysis of the vocabulary used in work logs of a preventive programme for elderly oral function and nutrition.

Ito K, Edahiro A, Watanabe Y, Ohara Y, Motohashi Y, Morishita S, Motokawa K, Watanabe Y, Hirano H, Inoue M.

J Oral Rehabil. 2019 Aug;46(8):723-729. doi: 10.1111/joor.12804. Epub 2019 May 8.

32.

Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.

Edahiro Y, Araki M, Inano T, Ito M, Morishita S, Misawa K, Fukuda Y, Imai M, Ohsaka A, Komatsu N.

Eur J Haematol. 2019 Jun;102(6):516-520. doi: 10.1111/ejh.13236. Epub 2019 Apr 25.

PMID:
30977935
33.

Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy.

Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N.

Haematologica. 2019 Nov;104(11):e506-e509. doi: 10.3324/haematol.2018.208876. Epub 2019 Apr 4. No abstract available.

34.
35.

Involvement of premacular mast cells in the pathogenesis of macular diseases.

Sato T, Morishita S, Horie T, Fukumoto M, Kida T, Oku H, Nakamura K, Takai S, Jin D, Ikeda T.

PLoS One. 2019 Feb 22;14(2):e0211438. doi: 10.1371/journal.pone.0211438. eCollection 2019.

36.

Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma.

Tanaka T, Morishita S, Hashimoto M, Nakamichi T, Uchiyama Y, Hasegawa S, Domen K.

Support Care Cancer. 2019 Nov;27(11):4107-4113. doi: 10.1007/s00520-019-04704-5. Epub 2019 Feb 20.

PMID:
30788627
37.

A framework and an algorithm to detect low-abundance DNA by a handy sequencer and a palm-sized computer.

Masutani B, Morishita S.

Bioinformatics. 2019 Feb 15;35(4):584-592. doi: 10.1093/bioinformatics/bty663.

PMID:
30776078
38.

Face scale rating of perceived exertion during cardiopulmonary exercise test.

Morishita S, Tsubaki A, Nashimoto S, Fu JB, Onishi H.

BMJ Open Sport Exerc Med. 2018 Dec 17;4(1):e000474. doi: 10.1136/bmjsem-2018-000474. eCollection 2018.

39.

CNV analysis using whole exome sequencing identified biallelic CNVs of VPS13B in siblings with intellectual disability.

Enomoto Y, Tsurusaki Y, Yokoi T, Abe-Hatano C, Ida K, Naruto T, Mitsui J, Tsuji S, Morishita S, Kurosawa K.

Eur J Med Genet. 2020 Jan;63(1):103610. doi: 10.1016/j.ejmg.2018.12.015. Epub 2018 Dec 30.

PMID:
30602132
40.

Rating of perceived exertion on resistance training in elderly subjects.

Morishita S, Tsubaki A, Nakamura M, Nashimoto S, Fu JB, Onishi H.

Expert Rev Cardiovasc Ther. 2019 Feb;17(2):135-142. doi: 10.1080/14779072.2019.1561278. Epub 2019 Jan 7. Review.

PMID:
30569775
41.

Neuroimaging, genetic, and enzymatic study in a Japanese family with a GBA gross deletion.

Ichinose Y, Ishiura H, Tanaka M, Yoshimura J, Doi K, Umeda T, Yamauchi H, Tsuchiya M, Koh K, Yamashiro N, Mitsui J, Goto J, Onishi H, Ohtsuka T, Shindo K, Morishita S, Tsuji S, Takiyama Y.

Parkinsonism Relat Disord. 2019 Apr;61:57-63. doi: 10.1016/j.parkreldis.2018.11.028. Epub 2018 Dec 2.

PMID:
30528172
42.

Rab5 activation on macropinosomes requires ALS2, and subsequent Rab5 inactivation through ALS2 detachment requires active Rab7.

Morishita S, Wada N, Fukuda M, Nakamura T.

FEBS Lett. 2019 Jan;593(2):230-241. doi: 10.1002/1873-3468.13306. Epub 2018 Dec 7.

43.

Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment.

Matsumura K, Morishita S, Taniguchi N, Takehana K, Takahashi H, Otagaki M, Yoshioka K, Yamamoto Y, Takagi M, Shiojima I.

Heart Vessels. 2019 Apr;34(4):607-615. doi: 10.1007/s00380-018-1290-6. Epub 2018 Nov 1.

PMID:
30386917
44.

Effect of Eye-Object Distance on Body Sway during Galvanic Vestibular Stimulation.

Aoki O, Otani Y, Morishita S.

Brain Sci. 2018 Oct 23;8(11). pii: E191. doi: 10.3390/brainsci8110191.

45.

Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS.

Naruse H, Ishiura H, Mitsui J, Takahashi Y, Matsukawa T, Tanaka M, Doi K, Yoshimura J, Morishita S, Goto J, Toda T, Tsuji S.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):537-542. doi: 10.1136/jnnp-2018-318568. Epub 2018 Oct 24.

PMID:
30355605
46.

Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis.

Nakano J, Hashizume K, Fukushima T, Ueno K, Matsuura E, Ikio Y, Ishii S, Morishita S, Tanaka K, Kusuba Y.

Integr Cancer Ther. 2018 Dec;17(4):1048-1058. doi: 10.1177/1534735418807555. Epub 2018 Oct 23.

47.

Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins.

Kida T, Flammer J, Oku H, Konieczka K, Morishita S, Horie T, Ikeda T.

Data Brief. 2018 Sep 29;21:59-62. doi: 10.1016/j.dib.2018.09.070. eCollection 2018 Dec.

48.

Distribution of Pacini-Like Lamellar Corpuscles in the Vascular Sheath of the Femoral Artery.

Morishita S, Sai K, Maeda S, Kuwahara-Otani S, Minato Y, Yagi H.

Anat Rec (Hoboken). 2018 Nov;301(11):1809-1814. doi: 10.1002/ar.23934. Epub 2018 Oct 8.

49.

Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.

Tsuchiya K, Tabe Y, Ai T, Ohkawa T, Usui K, Yuri M, Misawa S, Morishita S, Takaku T, Kakimoto A, Yang H, Matsushita H, Hanami T, Yamanaka Y, Okuzawa A, Horii T, Hayashizaki Y, Ohsaka A.

PLoS One. 2018 Oct 3;13(10):e0202429. doi: 10.1371/journal.pone.0202429. eCollection 2018.

50.

A framework and an algorithm to detect low-abundance DNA by a handy sequencer and a palm-sized computer.

Masutani B, Morishita S.

Bioinformatics. 2019 Apr 15;35(8):1443. doi: 10.1093/bioinformatics/bty771. No abstract available.

PMID:
30252019

Supplemental Content

Loading ...
Support Center